how glp 1 agonists work Mechanisms of action of GLP-1RA Part 2 of a 3-Part

Discover how microdosing GLP-1s can have low side effects, low costs, and support weight loss

Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality

Developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) has been a surprisingly challenging task

GIP works with GLP-1 to lower blood sugar, reduce appetite, and also helps your body process fat.How does the dosing work?To prevent side effects, these medications should be started at a low dose and increased over time

Risk of bias was assessed using an adapted Quality Assessment Tool for In Vitro Studies (QUIN) tool

Semaglutide 2.4mg once weekly, a subcutaneously administered GLP-1 RA approved for obesity treatment in 2021, results in 1517% mean weight loss (WL) with evidence of cardioprotection